Mithra sells shares in Mayne Pharma
February 15, 2024 12:23 ET
|
Mithra Pharmaceuticals
Mithra sells shares in Mayne Pharma Mithra sold all 4,221,815 shares it held in Mayne Pharma for EUR ~12.8 millionAs the Mayne Pharma shares were pledged to the secured lenders of Mithra,...
Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients
December 20, 2023 11:45 ET
|
Mithra Pharmaceuticals
Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients Important milestone for Mithra’s commitment to bring benefits of ESTELLE® to more womenPotential EMA approval in pediatric...
Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China
December 04, 2023 01:00 ET
|
Mithra Pharmaceuticals
Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China Mithra signs binding Head of Terms for a twenty-year partnership with Gedeon-Richter...
Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement
October 23, 2023 01:00 ET
|
Mithra Pharmaceuticals
Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement Relates to the submission of a marketing approval application in JapanMarks strong...
Mithra présentera ses résultats financiers du premier semestre 2023 à ses investisseurs lors d'une conférence web le 26 septembre à 14 h 00 CET
September 22, 2023 07:30 ET
|
Mithra Pharmaceuticals
Mithra présentera ses résultats financiers du premier semestre 2023 à ses investisseurs lors d'une conférence web le 26 septembre à 14 h 00 CET Liège, Belgique, 22 septembre 2023 – 13 h 30 CET –...
Letter to Shareholders and Corporate Update
September 11, 2023 01:30 ET
|
Mithra Pharmaceuticals
Letter to Shareholders and Corporate Update Liege, Belgium, 11 September 2023 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, (the “Company” or “Mithra”),...
Mithra Receives EUR 1.25 Million Milestone Payment from Fuji Pharma under Estelle® Licensing Agreement
August 03, 2023 01:30 ET
|
Mithra Pharmaceuticals
Mithra Receives EUR 1.25 Million Milestone Payment from Fuji Pharma under Estelle® Licensing Agreement Relates to completion of the interim clinical study reports of Phase 3 trials in patients...
Mithra and Searchlight Pharma Announce Donesta® Licensing Agreement for Canada
July 31, 2023 01:30 ET
|
Mithra Pharmaceuticals
Mithra and Searchlight Pharma Announce Donesta® Licensing Agreement for Canada Mithra to receive up to €17.05 million in licensing fees and regulatory and sales milestones, along with tiered...
Mithra and Searchlight Pharma Announce Donesta® Licensing Agreement for Canada
July 31, 2023 01:30 ET
|
Mithra Pharmaceuticals
Mithra and Searchlight Pharma Announce Donesta® Licensing Agreement for Canada Mithra to receive up to €17.05 million in licensing fees and regulatory and sales milestones, along with tiered...
Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025
July 17, 2023 11:45 ET
|
Mithra Pharmaceuticals
Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025 (ISIN: BE6325746855) Liege, Belgium, 17 July 2023 – 17:45 CEST – Mithra...